Sign inGet started

Martell Bridget A

Insider CIK 1629627 · KURA Acting Chief Medical Officer · ALGS Director · PNT Director · CBRX Chief Medical Officer · DCTH Director · ACHV Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALGS Aligos Therapeutics, Inc. A Award deriv2026-06-252026-06-295,860— $05,860SEC↗
DCTH DELCATH SYSTEMS, INC. A Award deriv2026-05-132026-05-1422,500— $022,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2025-06-252025-06-265,860— $05,860SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2025-06-062025-06-1031,500— $031,500SEC↗
DCTH DELCATH SYSTEMS, INC. A Award deriv2025-05-152025-05-1922,500— $022,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2024-06-272024-06-2860,000— $060,000SEC↗
DCTH DELCATH SYSTEMS, INC. A Award deriv2024-05-232024-05-2822,500— $022,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2024-02-282024-02-288,823— $08,823SEC↗
ALGS Aligos Therapeutics, Inc. D To issuer deriv2024-02-272024-02-2830,000— $00SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2024-01-222024-01-2931,500— $031,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2023-07-202023-07-2120,000— $020,000SEC↗
PNT POINT Biopharma Global Inc A Award deriv2023-06-132023-06-1480,503— $080,503SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2023-06-072023-06-0931,500— $031,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2022-06-232022-06-2715,000— $015,000SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2022-05-312022-06-014,400— $04,400SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2021-11-162021-11-1830,000— $030,000SEC↗
ACHV ACHIEVE LIFE SCIENCES, INC A Award deriv2021-03-152021-03-175,650— $05,650SEC↗
KURA Kura Oncology, Inc. A Award deriv2020-02-102020-02-1250,000— $050,000SEC↗
KURA Kura Oncology, Inc. A Award deriv2020-02-102020-02-1250,000— $050,000SEC↗
JNP JUNIPER PHARMACEUTICALS IN A Award deriv2017-03-032017-03-0774,900— $074,900SEC↗
JNP JUNIPER PHARMACEUTICALS IN A Award2017-03-032017-03-0715,500— $015,500SEC↗
JNP JUNIPER PHARMACEUTICALS IN A Award deriv2016-02-192016-07-0650,000— $050,000SEC↗
CBRX COLUMBIA LABORATORIES INC A Award deriv2015-01-062015-01-0960,000— $060,000SEC↗